Articles

Transfer Factor for Autism Spectrum

Transfer Factors unique effects are achieved by lowering the burden of chronic viral/bacterial infections (e.g. measles, streptococcus, etc. present in Autism Sprectum), correcting immune abnormalities (including auto-immunity) and lowering allergic tendency (foods, dust, molds, etc.). See ‘What is Transfer Factor and where can I get it?’ to read more information about TF and to find out how to order it.

Study 1.

Fudenberg HH. Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study. Biotherapy. 1996;9(1-3):143-7.

Neurolmmuno Therapeutics Research Foundation Spartanburg, S.C., USA.

40 infantile autistic patients were studied. They ranged from 6 years to 15 years of age at entry. 22 were cases of classical infantile autism; whereas 18 lacked one or more clinical defects associated with infantile autism ("pseudo-autism"). Of the 22 with classic autism, 21 responded to transfer factor (TF) treatment by gaining at least 2 points in symptoms severity score average (SSSA); and 10 became normal in that they were main-streamed in school and clinical characteristics were fully normalized. Of the 18 remaining, 4 responded to TF, some to other therapies. After cessation of TF therapy, 5 in the autistic group and 3 of the pseudo-autistic group regressed, but they did not drop as low as baseline levels.

Study 2.

Kenneth Bock, MD. Transfer Factor Study with Autistic Children.

9 children, ages: 2.9-9.9 (average age: 5.07). These children were given three capsules of Transfer Factor, three times daily, for three months. Each patient was assessed prior to the treatment, six weeks into the study, and at the completion of the three-month study. Dr. Bock used the Gilliam Autism Rating Scale for evaluation purposes. This method applies different scores based on: stereotyped "autistic" behaviors, communication, social interaction and developmental markers. These scores are then added together to determine an autism quotient. The higher the autism quotient is, the higher the degree of autism in the patient.

At the end of the three-month study, seven out of the nine autistic children had at least some improvement. Specifically, these improvements included:

Clinical observation of Dr. David Markowitz (Paediatrician).

"Some interesting observations from 4-5 kids with autism in our practice. All were started on transfer factors as a means to boost their immune system and hopefully keep them healthier. Well, that worked! But interestingly, all have shown better communication skills, better interactive skills, and less self-stimulatory behavior. Parents are delighted. Dr. Ken Bock in NY has seen similar observations. Amazing what a boosted immune system can do."

Blake Graham, BSc (Honours), AACNEM
Clinical Nutritionist
Perth, Western Australia
Phone/Email: See Contact page
*Non-Perth residents may enquire about phone consultations.

Return to the top of the page